Literature DB >> 35762436

[Association of liver damage with coronary artery lesion and no response to intravenous immunoglobulin in the acute stage of Kawasaki disease].

Hui-Min Hu1, Xiao-Zheng Chen, Yong-Lan Zhang1, Zhong-Dong DU1.   

Abstract

OBJECTIVES: To summarize the clinical features of liver damage in children in the acute stage of Kawasaki disease (KD), and to investigate the clinical value of liver damage in predicting coronary artery lesion and no response to intravenous immunoglobulin (IVIG) in children with KD.
METHODS: The medical data were collected from 925 children who were diagnosed with KD for the first time in Beijing Children's Hospital from January 1, 2016 to December 31, 2017. According to the presence or absence of abnormal alanine aminotransferase (ALT) level on admission, the children were divided into a liver damage group (n=284) and a non-liver damage group (n=641). A logistic regression analysis was used to investigate the clinical value of the indicators including liver damage in predicting coronary artery lesion and no response to IVIG in children with KD.
RESULTS: Compared with the non-liver damage group, the liver damage group had a significantly earlier admission time and significantly higher serum levels of inflammatory indicators (P<0.05). The liver damage group had a significantly higher incidence rate of coronary artery lesion on admission than the non-liver damage group (P=0.034). After initial IVIG therapy, the liver damage group had a significantly higher proportion of children with no response to IVIG than the non-liver damage group (P<0.001). In children with KD, coronary artery lesion was associated with the reduction in the hemoglobin level and the increases in platelet count, C-reactive protein, and ALT (P<0.05), and no response to IVIG was associated with limb changes, the reduction in the hemoglobin level, the increases in platelet count, C-reactive protein, and ALT, and coronary artery lesion (P<0.05).
CONCLUSIONS: Compared with those without liver damage, the children in the early stage of KD with liver damage tend to develop clinical symptoms early and have higher levels of inflammatory indicators, and they are more likely to have coronary artery lesion and show no response to IVIG treatment.

Entities:  

Keywords:  Child; Coronary artery lesion; Immunoglobulin; Kawasaki disease; Liver damage

Mesh:

Substances:

Year:  2022        PMID: 35762436      PMCID: PMC9250406          DOI: 10.7499/j.issn.1008-8830.2112094

Source DB:  PubMed          Journal:  Zhongguo Dang Dai Er Ke Za Zhi        ISSN: 1008-8830


  20 in total

1.  Aging of cardiac myocytes in culture: oxidative stress, lipofuscin accumulation, and mitochondrial turnover.

Authors:  Alexei Terman; Helge Dalen; John W Eaton; Jiri Neuzil; Ulf T Brunk
Journal:  Ann N Y Acad Sci       Date:  2004-06       Impact factor: 5.691

2.  Abnormal liver panel in acute kawasaki disease.

Authors:  Mohammed Eladawy; Samuel R Dominguez; Marsha S Anderson; Mary P Glodé
Journal:  Pediatr Infect Dis J       Date:  2011-02       Impact factor: 2.129

3.  Platelet Count Variation and Risk for Coronary Artery Abnormalities in Kawasaki Disease.

Authors:  Ryusuke Ae; Joseph Y Abrams; Ryan A Maddox; Lawrence B Schonberger; Yosikazu Nakamura; Asuka Shindo; Masanari Kuwabara; Nobuko Makino; Yuri Matsubara; Koki Kosami; Teppei Sasahara; Ermias D Belay
Journal:  Pediatr Infect Dis J       Date:  2020-03       Impact factor: 2.129

4.  Procalcitonin as a Biomarker of Unresponsiveness to Intravenous Immunoglobulin for Kawasaki Disease.

Authors:  Nami Nakamura; Taichiro Muto; Yu Masuda; Shingo Numoto; Shunsuke Kodama; Ryosuke Miyamoto; Kenji Miyata; Tomohito Hayakawa; Hiromitsu Mori; Yoshiyuki Kuroyanagi; Mitsuko Akaihata; Hideyuki Iwayama; Hirokazu Kurahashi; Yasuhito Shimomura; Takuhito Nagai; Toshinori Hori; Hiroatsu Agata; Akihisa Okumura
Journal:  Pediatr Infect Dis J       Date:  2020-09       Impact factor: 2.129

Review 5.  Diagnosis, Treatment, and Long-Term Management of Kawasaki Disease: A Scientific Statement for Health Professionals From the American Heart Association.

Authors:  Brian W McCrindle; Anne H Rowley; Jane W Newburger; Jane C Burns; Anne F Bolger; Michael Gewitz; Annette L Baker; Mary Anne Jackson; Masato Takahashi; Pinak B Shah; Tohru Kobayashi; Mei-Hwan Wu; Tsutomu T Saji; Elfriede Pahl
Journal:  Circulation       Date:  2017-03-29       Impact factor: 29.690

6.  [The expert consensus on diagnosis and acute-phase treatment of Kawasaki disease].

Authors: 
Journal:  Zhonghua Er Ke Za Zhi       Date:  2022-01-02

7.  Inflammatory cytokines as predictors of resistance to intravenous immunoglobulin therapy in Kawasaki disease patients.

Authors:  Satoshi Sato; Hisashi Kawashima; Yasuyo Kashiwagi; Akinori Hoshika
Journal:  Int J Rheum Dis       Date:  2013-04       Impact factor: 2.454

8.  Descriptive epidemiology of Kawasaki disease in Japan, 2011-2012: from the results of the 22nd nationwide survey.

Authors:  Nobuko Makino; Yosikazu Nakamura; Mayumi Yashiro; Ryusuke Ae; Satoshi Tsuboi; Yasuko Aoyama; Takao Kojo; Ritei Uehara; Kazuhiko Kotani; Hiroshi Yanagawa
Journal:  J Epidemiol       Date:  2015-02-07       Impact factor: 3.211

Review 9.  Epidemiology of Kawasaki disease in Asia, Europe, and the United States.

Authors:  Ritei Uehara; Ermias D Belay
Journal:  J Epidemiol       Date:  2012-02-04       Impact factor: 3.211

10.  Distribution of Diseases Causing Liver Function Test Abnormality in Children and Natural Recovery Time of the Abnormal Liver Function.

Authors:  Mirinae Jang; Min Su Oh; Se Cheol Oh; Ki Soo Kang
Journal:  J Korean Med Sci       Date:  2016-11       Impact factor: 2.153

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.